13 Recruiting Studies Using Luspatercept
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Luspatercept
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
π Local Institution - 0070 β Clovis, California
Myelodysplastic Syndromes
View Study & Checklist βA Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept
π Bristol Myers Squibb β Princeton, New Jersey
Myelodysplastic Syndromes (MDS)
View Study & Checklist βA Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
π Local Institution - 0051 β Los Alamitos, California
Myelodysplastic Syndromes
View Study & Checklist βLuspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
π Moffitt Cancer Center β Tampa, Florida
Myelodysplastic Syndromes
View Study & Checklist βA Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA NaΓ―ve
π Local Institution - 107 β Berkeley, California
Myelodysplastic Syndromes
View Study & Checklist βA Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
π M D Anderson Cancer Center β Houston, Texas
Myelodysplastic Syndromes
View Study & Checklist βLuspatercept + Darbepoetin in MDS
π Yale University β New Haven, Connecticut
MDS (Myelodysplastic Syndrome)
View Study & Checklist βA Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (Ξ±)-Thalassemia
π Local Institution - 0008 β Halifax, Nova Scotia
Anemia
View Study & Checklist βStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
π GSK Investigational Site β Ann Arbor, Michigan
Primary Myelofibrosis
View Study & Checklist βLuspatercept for Clonal Cytopenias of Uncertain Significance
π Weill Cornell Medical College β New York, New York
CCUS Clonal Cytopenia of Undetermined Significance
View Study & Checklist βMYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
π University of Alabama at Birmingham Cancer Center β Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist βA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
π Local Institution - 968 β Los Angeles, California
Myelodysplastic Syndromes (MDS)
View Study & Checklist βA Study of Luspatercept in People With Anemia
π Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
Anemia
View Study & Checklist β